Bellevue Group’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$26.8K Buy
2022
Q4
Sell
2022
Q3
$1.71M Buy
2022
Q2
$817K Sell
2022
Q1
$1.18M Sell
2021
Q4
$1.96M Hold
2021
Q3
$2.23M Buy
2019
Q1
Sell
2018
Q4
$216K Sell
2018
Q3
$470K Sell
2018
Q2
$458K Buy